Transcript Prezentacja programu PowerPoint

POLISH INFORMATION
AND FOREIGN INVESTMENT AGENCY
Economy & biotech industry in Poland
Marek Łyżwa
Vice-President
PAIiIZ
Washington DC, June 27
1
GDP growth in 2009
- 6.5%
- 7.8%
EU27: - 4.2%
USA: - 2.4%
Poland – green island
on the map of Europe
- 1.5%
- 14.1%
- 5.1%
Japan: - 5.2%
- 18%
-4.9%
- 7.1%
- 14.8%
- 4.9%
PL
+ 1.7%
-4%
-3%
- 4.9%
- 4.2%
- 4.7%
- 3.6%
- 2.6%
- 1.5%
- 7.8%
- 5.0%
- 6.3%
- 7.1%
- 5.8%
- 5.0%
- 3.6%
- 2.7%
- 2.0%
Source: Eurostat, 2010
2
Poland seen by international companies
– A.T. Kearney FDI Confidence Index 2010
• Poland – the biggest increase
in comparison to the previous edition
(of 2007);
Country
• 2nd place in Europe, 6th place in the
world.
16
15
top 15 differences
11
5
4
2
2
1
0
0
0
-15
Source: AT Kearney, 2010.
France
Vietnam
China
USA
Other
Persian
Brazil
Australia
Canada
Germany
-10
Mexico
-5
Poland
0
-1 -3 -6 -9
Hong
Kong
5
UK
5
UEA
10
India
20
2010
rank
2007
rank
Differen
ce
China
1
1
0
USA
2
3
1
India
3
2
-1
Brazil
4
6
2
Germany
5
10
5
Poland
6
22
16
Australia
7
11
4
Mexico
8
19
11
Canada
9
14
5
UK
10
4
-6
UEA
11
8
-3
Vietnam
12
12
0
France
13
13
0
Hong Kong
14
5
-9
Other Persian
Gulf countries
15
17
2
3
Poland’s strengths, UNCTAD
Poland’s main strengths are:
• Growth of the market
• Size of domestic market
• Access to regional markets
• Cooperation with suppliers and
business partners
• Investment incentives system
• Stable investment environment
Poland is the 11th most attractive investment location in the
world
Source: UNCTAD, World Investment Prospects Survey 2009-2011.
4
The inflow of FDI to CEE countries in 2010 (EUR bn )
9.9
7.5
0.6
-0.3
Lithuania
4.6
1.9
Poland
3.5
2.6
Czech. Rep.
Romania
2009 2010
5
All projects served by PAIiIZ in June 2011
Countries
50
40
43
36
14
13
10
9
8
8
5
2
1
Brazil
15
20
Spain
30
Other
India
Japan
France
Germany
China
Korea
Great
Britain
USA
0
Active projects served by PAIiIZ: 154
Value: EUR 5 514 mio
Jobs: 36 204
Source: PAIiIZ, June, 2011.
6
Services and Manufacturing Hub in Poland (1)
Automotive
White goods
Electronics
7
Services and Manufacturing Hub in Poland (2)
Aviation
BPO
R&D
8
Polish biotechnology in numbers
The market for biotechnology which can be used in
pharmaceuticals and medicine (“red biotechnology”)
is growing in Poland. Biotechnological firms are
working hard on new products, the sales of which
will have a substantial impact on the rate of further
growth of the industry over the next years.
In 2010, despite the difficult economic situation,
sales of market players grew (e.g. Bioton – 75%,
Mabion – more than 200%), which should lead to
the improvement of the entire market (30% year-onyear increase in 2011). This is a consequence of
the development of innovative projects
conducted in recent years and a result of EU
financial support
Source: PMR
9
Polish biotechnology sector development
The availability of EU funds in Poland has made it
possible to support the development of biotech
investments.
According to the Ministry of Economy, between
2007 and 2013 companies and scientific institutions
in the medical, pharmaceutical and biotechnological
industries will implement projects worth around
€150m (The Innovative Economy Operational
Program).
The fact that Polish biotech sector are just beginning to develop
intensively is best illustrated by the number of new innovative ventures
carried out by companies such as: Celther, Celon Pharma, Mabion,
Euroimplant, Biocontract.
Currently PAIiIZ is working with leading world company on the
significant project of plasma fractionation in Poland.
Source: PMR, PAIiIZ
10
Why Poland?
Strategic location – gateway to the EU
Economic and political stability
Availability of skilled human resources
Effective incentive system including EU-Funds
11
Thank you for your attention
00-585 Warszawa, ul. Bagatela 12
tel. (+48 22) 334 98 00, fax (+48 22) 334 99 99
e-mail: [email protected]
12